Matches in SemOpenAlex for { <https://semopenalex.org/work/W2892335150> ?p ?o ?g. }
Showing items 1 to 65 of
65
with 100 items per page.
- W2892335150 abstract "e18052 Background: Drugs in the USA become available from the moment of FDA approval. Access to oncology therapies outside of the USA may be delayed by regulatory and additional payer HTA processes. This study aimed to examine differences in oncology conditions that may impact time from regulatory approval to an HTA reimbursement decision in countries with mandatory HTA. Methods: Oncology HTAs (N = 569) for medicines approved by the EMA, Health Canada, and the Therapeutic Goods Administration (Australia) were matched on indication with HTAs from France, Germany, Canada, England, Scotland, and Australia. Resubmissions were excluded. The date of the first reimbursement decision was subtracted from the date of the regulatory approval to determine the time to issue a reimbursement decision. Trends by disease were examined. Results: The time between regulatory approval and reimbursement decision was significantly longer for solid-state oncology drugs than for hematology oncology drugs (mean 344 days vs. 280 days, respectively; p = 0.03). Within hematology oncology, Non-Hodgkin’s Lymphoma had the shortest time to a decision (229 days; n = 37) while Myelofibrosis had the longest (411 days; n = 3). For solid-state diseases, Sarcoma had the shortest time (5 days; n = 2) and Small-cell Lung Cancer had the longest (752 days; n = 5) time to a decision. Conclusions: Time to patient access to oncology medications varies by disease condition, which may reflect disease-related factors that impact assessment. The time to a decision for a hematology medicine was approximately two months shorter than the time to a decision for a solid-state medicine. It is possible that unmet need, budget impact, or competitive features within hematology conditions are driving the speed of assessments in these medicines. Further research is needed to determine why there are differences in time to decisions by oncology disease conditions." @default.
- W2892335150 created "2018-09-27" @default.
- W2892335150 creator A5027729351 @default.
- W2892335150 creator A5028490559 @default.
- W2892335150 creator A5034879617 @default.
- W2892335150 date "2017-05-20" @default.
- W2892335150 modified "2023-09-23" @default.
- W2892335150 title "An exploration of how a countries' HTA process can affect patient access." @default.
- W2892335150 doi "https://doi.org/10.1200/jco.2017.35.15_suppl.e18052" @default.
- W2892335150 hasPublicationYear "2017" @default.
- W2892335150 type Work @default.
- W2892335150 sameAs 2892335150 @default.
- W2892335150 citedByCount "1" @default.
- W2892335150 countsByYear W28923351502019 @default.
- W2892335150 crossrefType "journal-article" @default.
- W2892335150 hasAuthorship W2892335150A5027729351 @default.
- W2892335150 hasAuthorship W2892335150A5028490559 @default.
- W2892335150 hasAuthorship W2892335150A5034879617 @default.
- W2892335150 hasConcept C138885662 @default.
- W2892335150 hasConcept C143998085 @default.
- W2892335150 hasConcept C177713679 @default.
- W2892335150 hasConcept C2775832928 @default.
- W2892335150 hasConcept C2776035688 @default.
- W2892335150 hasConcept C2780035454 @default.
- W2892335150 hasConcept C2992293740 @default.
- W2892335150 hasConcept C41895202 @default.
- W2892335150 hasConcept C71924100 @default.
- W2892335150 hasConcept C98274493 @default.
- W2892335150 hasConceptScore W2892335150C138885662 @default.
- W2892335150 hasConceptScore W2892335150C143998085 @default.
- W2892335150 hasConceptScore W2892335150C177713679 @default.
- W2892335150 hasConceptScore W2892335150C2775832928 @default.
- W2892335150 hasConceptScore W2892335150C2776035688 @default.
- W2892335150 hasConceptScore W2892335150C2780035454 @default.
- W2892335150 hasConceptScore W2892335150C2992293740 @default.
- W2892335150 hasConceptScore W2892335150C41895202 @default.
- W2892335150 hasConceptScore W2892335150C71924100 @default.
- W2892335150 hasConceptScore W2892335150C98274493 @default.
- W2892335150 hasLocation W28923351501 @default.
- W2892335150 hasOpenAccess W2892335150 @default.
- W2892335150 hasPrimaryLocation W28923351501 @default.
- W2892335150 hasRelatedWork W1828497742 @default.
- W2892335150 hasRelatedWork W1954039434 @default.
- W2892335150 hasRelatedWork W1972105056 @default.
- W2892335150 hasRelatedWork W2085537320 @default.
- W2892335150 hasRelatedWork W2102930214 @default.
- W2892335150 hasRelatedWork W2104263006 @default.
- W2892335150 hasRelatedWork W2139366207 @default.
- W2892335150 hasRelatedWork W2145291234 @default.
- W2892335150 hasRelatedWork W2146178271 @default.
- W2892335150 hasRelatedWork W2212551923 @default.
- W2892335150 hasRelatedWork W2298699284 @default.
- W2892335150 hasRelatedWork W2338367129 @default.
- W2892335150 hasRelatedWork W2339826901 @default.
- W2892335150 hasRelatedWork W2755632045 @default.
- W2892335150 hasRelatedWork W2765609623 @default.
- W2892335150 hasRelatedWork W2807149422 @default.
- W2892335150 hasRelatedWork W2889973949 @default.
- W2892335150 hasRelatedWork W3048730778 @default.
- W2892335150 hasRelatedWork W3092099373 @default.
- W2892335150 hasRelatedWork W3207736722 @default.
- W2892335150 isParatext "false" @default.
- W2892335150 isRetracted "false" @default.
- W2892335150 magId "2892335150" @default.
- W2892335150 workType "article" @default.